`Patent No. 6,667,061
`Petitioners’ Notice of Deposition
`Attorney Docket No. 9LUYE 7.1R-004
`
`
`UNITED STATES PATENT AND TRADEMARK OFFICE
`____________________________
`
`BEFORE THE PATENT TRIAL AND APPEAL BOARD
`____________________________
`
`LUYE PHARMA GROUP LTD., LUYE PHARMA (USA) LTD., SHANDONG
`LUYE PHARMACEUTICAL CO., LTD., and NANJING LUYE
`PHARMACEUTICAL CO., LTD.
`Petitioners
`
`v.
`
`ALKERMES PHARMA IRELAND LTD. and
`ALKERMES CONTROLLED THERAPEUTICS, INC.
`Patent Owners.
`
`
`
`Patent No. 6,667,061 to Ramstack et al.
`Issue Date: December 23, 2003
`Title: PREPARATION OF INJECTABLE
`SUSPENSIONS HAVING IMPROVED INJECTABILITY
`____________________________
`Inter Partes Review No. IPR2016-01096
`__________________________________________________________________
`
`PETITIONERS’ REVISED NOTICE OF DEPOSITION OF
`DR. CORY BERKLAND PURSUANT TO 37 C.F.R. § 42.53
`
`
`
`4987512_1.docx
`
`
`
`Case IPR2016-01096
`Petitioners’ Notice of Deposition
`Patent No. 6,667,061
`Attorney Docket No. 9LUYE 7.1R-004
`
`
`Pursuant to 37 C.F.R. § 42.53, Petitioners Luye Pharma Group Ltd., Luye
`
`Pharma (USA) Ltd., Shandong Luye Pharmaceutical Co., Ltd., and Nanjing Luye
`
`Pharmaceutical Co., Ltd. (“Luye”) by and through their attorneys will conduct
`
`cross-examination by deposition of Dr. Cory Berkland. The deposition will take
`
`place starting at 9:30 a.m. on May 26, 2017 at Fitzpatrick, Cella, Harper & Scinto,
`
`1290 Avenue of the Americas, New York, NY 10104-3800. In accordance with
`
`37 C.F.R. § 42.53(d)(1), the parties have conferred and agreed upon this time and
`
`place for Dr. Berkland’s deposition. The cross-examination will be taken before a
`
`Notary Public or other officer authorized by law to administer oaths by both
`
`stenographic and videographic means.
`
`Respectfully submitted,
`
`
`
`
`
`s/ Paul H. Kochanski /
`Paul H. Kochanski (Reg.No. 29,660)
`LERNER, DAVID, LITTENBERG,
` KRUMHOLZ & MENTLIK, LLP
`600 South Avenue West
`Westfield, NJ 07090-1496
`Tel: 908.654.5000
`Fax: 908.654.7866
`pkochanski@lernerdavid.com
`
`
`
`Dated:
`
`May 11, 2017
`
`
`
`
`
`
`
`2
`
`4987512_1.docx
`
`
`
`Case IPR2016-01096
`Petitioners’ Notice of Deposition
`Patent No. 6,667,061
`Attorney Docket No. 9LUYE 7.1R-004
`
`
`CERTIFICATE OF SERVICE
`The undersigned hereby certifies
`that a copy of
`
`the
`
`foregoing
`
`PETITIONERS’
`
`REVISED
`
`NOTICE OF
`
`DEPOSITION OF
`
`DR. CORY BERKLAND PURSUANT TO 37 C.F.R. § 42.53 was served on
`
`May 11, 2017, as follows.
`
`VIA E-MAIL
`
`FITZPATRICK, CELLA, HARPER & SCINTO
`Scott Reed
`sreed@fchs.com
`Justin J. Oliver
`joliver@fchs.com
`Ha Kung Wong
`hwong@fchs.com
`Christina Schwarz
`cschwarz@fchs.com
`Melinda Roberts
`mroberts@fchs.com
`Una Fan
`ufan@fchs.com
`
`alkermesipr@fchs.com
`
`Counsel for Patent Owners Alkermes Pharma Ireland
`Ltd. and Alkermes Controlled Therapeutics, Inc.
`
`May 11, 2017
`
`
`
`Respectfully submitted,
`
`By: s/ Paul H. Kochanski /
`Paul H. Kochanski
`Registration No. 29,660
`pkochanski@lernerdavid.com
`
`
`
`
`
`
`Dated:
`
`4987512_1.docx
`
`